Delivering Quality Healthcare Services using Clinical Pathways

Mater, Wasef; Ibrahim, Roliana

doi:10.5120/16556-1441

Cited by 9 publications

(8 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…CP specifies what must be done in certain clinical conditions and provides a treatment plan with service standards considered in accordance with evidence-based medicine (EBM) [14]. According to Mater, the first thing that needs to be done is to improve the quality of medical staff with knowledge related to CP before carrying out a good clinical pathway implementation [15]. So, it can be concluded that the content still needs to be improved, especially by determining the allocation of resources to train staff in the use of the CP form.Based on the ICPAT assessment, in dimension 5, the percentage of content is 25% and quality is 69%.…”

Section: Discussionmentioning

confidence: 99%

Analysis of Clinical Pathway Implementation of Urinary Tract Stones at Royal Prima General Hospital Medan

Subkhan

Suci

Ramadhan

2022

IJHP

View full text Add to dashboard Cite

In realizing individual health rights, health services are required to be able to place resources and organization efficiently with the advancement of medical world. Clinical pathway (CP) is a disease management tool used to reduce unnecessary variations in services to improve clinical outcomes and to control the use of resources (financial). Acute appendicitis is one of the most common causes of acute abdominal pain, with cases from 20-30% and increasing 32-72% at age of <60 years. Therefore, it is necessary to conduct a study on the implementation of CP in the RSU. Royal Prima Medan. This study was conducted by using mix method with a case study design. Qualitative data were taken by interview and observation with case manager, medical committee, and nurses (n = 5) and quantitative data were taken with simple descriptive from acute appendicitis CP documentation in medical records and ICPAT (January - September 2020, n = 117). The level of completeness for CP was 100% and form filling was 85%. ICPAT dimension 1 contents and quality are good, dimension 2 contents still lack, and quality is moderate, dimension 3 contents is good and quality is moderate, dimension 4 content in moderate criteria and quality is good, dimension 5 contents still lack and quality is moderate and dimension 6, contents is good and quality is in moderate category. Where the obstacles are due to lack of understanding and time constraints. The development of urinary tract stones CP is not quite optimal; it is necessary to conduct periodic socialization and training to support understanding in filling out CP.

show abstract

Section: Discussionmentioning

confidence: 99%

Analysis of Clinical Pathway Implementation of Urinary Tract Stones at Royal Prima General Hospital Medan

Subkhan

Suci

Ramadhan

2022

IJHP

View full text Add to dashboard Cite

show abstract

“…The method of presenting CPs must therefore be adapted to the needs and knowledge of very diverse recipients (patients, doctors, medical personnel) and also, as the research conducted by the authors has shown, to the context of its use (Szela ˛gowski and Berniak-Wo zny, 2019). Therefore, when modeling a CP, its legibility and standardization are extremely important, as is the ability to adjust the method and scope of the presented information to the context of its use (Mater and Ibrahim, 2014). The method of modeling CPs must take into account their unstructured and knowledge-intensive nature (Berniak-Wo zny and Szela ˛gowski, 2022; Andellini et al, 2017;Kirchmer et al, 2013;Mans et al, 2008).…”

Section: Proposal Of Bpmn Extensionmentioning

confidence: 99%

Proposal of BPMN extension with a view to effective modeling of clinical pathways

Szelągowski

Biernacki

Berniak-Woźny

et al. 2022

BPMJ

View full text Add to dashboard Cite

PurposeThe aim of the article is to propose BPMN extensions that facilitate the modeling of Clinical Pathways in a way that enables for various groups of users, the transfer of a much wider range of information in the form of process models without compromising their readability and usefulness.Design/methodology/approachThe paper uses the design science research methodology (DSRM) and covers phases of a design-oriented research project extending BPMN notation for clinical pathway modeling.FindingsThe article proposes extensions of BPMN in 5 areas, enabling standardization of the description of business processes of different natures and complexity and in turn meeting the needs and requirements of modeling clinical pathways and, more broadly speaking, knowledge-intensive business processes (kiBPs) in general. As shown by the evaluation carried out among medical personnel, the proposed extensions allow for the readable transfer of a considerably larger body of information relevant to the planned, conducted and assessed therapy (kiBPs) than the current BPMN 2.0 standard.Originality/valueThe BPMN extensions proposed in the article fill the gaps in this notation and do not require users to know many notations, which in practice is unrealistic. Defined extensions to the BPMN specification makes it possible to standardise the description of processes of different natures and levels of complexity. In this way, both simplified models (and views of models) dedicated to users unfamiliar with BPMN and models (or views) using advanced possibilities provided by BPMN can be based on one standard, even if they use only a small part of its possibilities.

show abstract

“…In the first dimension, it can be seen that although the informants have understood the identification of clinical pathways, they are not necessarily in line with the quality produced. Improvements can be made through the provision of periodic training to improve the process and quality of patient documentation outcomes (Mater and Ibrahim, 2014). A study in Nigeria reported that the blended learning approach was quite effective in increasing the knowledge and competence of each healthcare professional on clinical pathways (Eguzo et al, 2021).…”

Section: Content and Quality Evaluationmentioning

confidence: 99%

Clinical Pathway Implementation in ACS STEMI Patients

et al. 2022

View full text Add to dashboard Cite

Delay in handling patients with Acute ST-elevation myocardial infarction (STEMI) is the cause of high mortality and the incidence of MACE (Major Adverse Cardiac Event), so efforts are needed to reduce it by handling patients with Acute Coronary Syndrome (ACS) with the implementation of clinical pathways. This study evaluates the application of clinical pathways for ACS STEMI patients based on content and quality and evaluates the effectiveness of clinical pathways based on length of stay, total costs, and outcomes between ACS STEMI patients with clinical pathways and nonclinical pathways. This research uses mixed methods with an exploratory sequential approach. Evaluation of clinical pathways for ACS STEMI patients with a qualitative approach through in-depth interviews using the Integrated Care Pathway Appraisal Tool (ICPAT) questionnaire. Furthermore, a comparative approach is used to determine the effectiveness of clinical pathways based on length of stay, total costs and outcomes (outcomes) between ACS STEMI patients who have and do not have a clinical pathway. The study was conducted from November 2021 to April 2022 at the

show abstract

Delivering Quality Healthcare Services using Clinical Pathways

Cited by 9 publications

References 26 publications

Analysis of Clinical Pathway Implementation of Urinary Tract Stones at Royal Prima General Hospital Medan

Analysis of Clinical Pathway Implementation of Urinary Tract Stones at Royal Prima General Hospital Medan

Proposal of BPMN extension with a view to effective modeling of clinical pathways

Clinical Pathway Implementation in ACS STEMI Patients

Contact Info

Product

Resources

About